-
Omicron in the US: Likely in the Calm before a Surge
Key Points In today’s Recommendations for Industry, we discuss the rise of Omicron. Read more here. COVID deaths in the US surpass 800,000 (NYT). It is the highest known number of any country. Known virus cases in the US rose above 50 million and more than 1,200 people are dying from COVID-19 each day. The worldwide…
-
Omicron: A Beginning Understanding?
Key Points In today’s Recommendations for Industry, we discuss Omicron and what is beginning to be understood. Read more below. The CDC is currently recommending Americans avoid travel to France, Jordan, and Portugal as these countries have seen spikes in COVID-19 cases (The Hill). Additionally, the CDC has added other destinations to Level 4 travel…
-
Case Rates Fluctuating Around the Globe
In today’s Recommendations for Industry, we discuss the fluctuation in case rates. Read more below. At least 5 million people worldwide have died from Covid – though experts believe the total number is undoubtedly far higher. COVID-19 is responsible for more than five million confirmed deaths around the world –a loss that would wipe out…
-
COVID Protections: Keep on Keeping on
In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and recommendations for close contact, but vaccinated, workers who have no symptoms. Read more below. In order to increase over-the-counter COVID-19 test access, the U.S. Department of Health and Human Services and the National Institutes of Health are “investing $70 million from the American Rescue…
-
US & Global Hotspots Prompt Recommendation for Continued Protections
In today’s Recommendations for Industry, we discuss TAG’s Weekly COVID-19 Matrix, U.S. and global hotspots, continued masking, and vaccine booster shots. Read more below. The FDA has authorized Moderna and J&J booster shots. Additionally, they are allowing for the mixing and matching of different COVID-19 vaccines [NYT]. French pharmaceutical company, Valneva’s COVID-19 vaccine has demonstrated…
-
COVID-19 Trends Spur Cautious Optimism
In today’s Recommendations for Industry, we discuss the cautious optimism spurred by current COVID trends. Read more below. As you’ll see today in our Risk Matrix, COVID-19 cases have dropped 34% in the last month. However, this is not even across all states as some states like Alaska have seen increased cases and TPRs. Children,…
-
Some Optimism Seen, but Expect to Retain Controls into 2022
In today’s Recommendations for Industry, we discuss businesses continuing to follow COVID protocols into 2022 and look at TAG’s weekly Risk Matrix. Read more below. Johnson & Johnson has released that a COVID-19 booster of its vaccine could lead to a ninefold increase in antibodies [Helio]. The CDC, in a recent MMWR, has announced that…
-
Employee Wellness: Summer’s End Brings New COVID Questions and Stressors.
In today’s Recommendations for Industry, we discuss the newly surging COVID questions and stressors of employees and the impact on your business. Read more below. We’ve received many questions about the different Variants of Concern that are being discussed in the news; last Thursday, we discussed this and you can read more here. The FDA…
-
TAG Updates Workplace Delta Protections Based on New CDC Data
In today’s Recommendations for Industry, TAG has updated its current thinking and recommendations on necessary risk mitigation measures in the workplace. Read more below. When You’ve Been Fully Vaccinated, the CDC recently emphasized that wearing a mask to maximize protection against the new Delta variant can prevent possible spreading to others. Wearing a mask in…
-
TAG’s Take on New CDC Guidance and What’s Coming Down the Road
In today’s Recommendations for Industry, we discuss CDC’s new guidance for fully vaccinated people to mask indoors in high-risk areas, and mask and be tested if exposed to a person with COVID-19. We also look at TAG’s COVID-19 Risk Matrix to better understand what is happening around the country. Read more below. The C.D.C now…